Scarica l'app Stockscreener
9.75
8.19%
-0.87
Dopo l'orario di chiusura:
9.75
Uniqure N V Borsa (QURE) Ultime notizie
Sanofi Set To Shake Up Crowded Hemophilia Space After Qfitlia Approval - insights.citeline.com
Learn to Evaluate (QURE) using the Charts - news.stocktradersdaily.com
Stock Watch: Are Gene Therapy Prices Too High For Success? - insights.citeline.com
(QURE) Trading Report - Stock Traders Daily
uniQure (NASDAQ:QURE) Stock Rating Upgraded by StockNews.com - Defense World
Oppenheimer & Co. Inc. Buys New Stake in uniQure (NASDAQ:QURE) - Defense World
FY2025 Earnings Estimate for uniQure Issued By HC Wainwright - Defense World
uniQure (NASDAQ:QURE) Earns Buy Rating from HC Wainwright - Defense World
uniQure CFO Christian Klemt sells $107,407 in shares By Investing.com - Investing.com Australia
uniQure Reports 2024 Financial Results and Progress - TipRanks
uniQure’s chief medical officer sells shares worth $13,891 - Investing.com India
uniQure CFO Christian Klemt sells $107,407 in shares - Investing.com India
uniQure’s chief medical officer sells shares worth $13,891 By Investing.com - Investing.com South Africa
uniQure CEO Matthew Kapusta sells shares worth $291,628 By Investing.com - Investing.com South Africa
uniQure chief legal officer sells shares for $72,812 By Investing.com - Investing.com South Africa
uniQure CEO Matthew Kapusta sells shares worth $291,628 - Investing.com
uniQure chief legal officer sells shares for $72,812 - Investing.com
uniQure (NASDAQ:QURE) Stock Price Down 7.3% Following Analyst Downgrade - Defense World
Wells Fargo & Company Cuts uniQure (NASDAQ:QURE) Price Target to $30.00 - Defense World
What is William Blair’s Forecast for uniQure Q1 Earnings? - Defense World
Don't Ignore The Insider Selling In uniQure - Simply Wall St
Q1 Earnings Estimate for uniQure Issued By William Blair - Defense World
uniQure Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Insider Selling: uniQure (NASDAQ:QURE) CEO Sells 26,727 Shares of Stock - MarketBeat
uniQure (NASDAQ:QURE) CEO Matthew C. Kapusta Sells 6,717 Shares - MarketBeat
uniQure (NASDAQ:QURE) CFO Christian Klemt Sells 14,341 Shares - MarketBeat
uniQure (NASDAQ:QURE) CFO Christian Klemt Sells 2,916 Shares - MarketBeat
uniQure (NASDAQ:QURE) Releases Quarterly Earnings Results, Misses Expectations By $0.90 EPS - MarketBeat
uniQure (NASDAQ:QURE) Shares Down 9.5%Should You Sell? - MarketBeat
uniQure (NASDAQ:QURE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
uniQure (NASDAQ:QURE) Given Average Rating of “Buy” by Brokerages - Defense World
Uniqure NV earnings missed by $0.82, revenue fell short of estimates - Investing.com Australia
uniQure CEO Matthew Kapusta sells over $360,000 in stock By Investing.com - Investing.com South Africa
uniQure CEO Matthew Kapusta sells over $360,000 in stock - Investing.com India
uniQure CFO Christian Klemt sells shares worth over $186,000 By Investing.com - Investing.com South Africa
uniQure CFO Christian Klemt sells shares worth over $186,000 - Investing.com
Uniqure NV reports results for the quarter ended December 31Earnings Summary - TradingView
uniQure N.V. SEC 10-K Report - TradingView
UniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
uniQure Reports 2024 Financial Results and Company Progress - TradingView
uniQure N.V. Reports Progress with AMT-130 for Huntington’s Disease and Updates on Clinical Trials Across its Gene Therapy Pipeline - Nasdaq
uniQure Announces 2024 Financial Results and Highlights Recent Company Progress - GlobeNewswire
uniQure N.V.: A Potential Huntington's Play - Seeking Alpha
uniQure (QURE) Expected to Announce Earnings on Wednesday - Defense World
(QURE) Technical Data - Stock Traders Daily
Huntington's Disease Market Growth to Accelerate in Forecast - openPR
Pfizer nixes Roche-partnered hemophilia drug (PFE:NYSE) - Seeking Alpha
uniQure: Gene Therapy Specialist Looks Set For Upside As Huntington's Approval Beckons - Seeking Alpha
uniQure N.V. (NASDAQ:QURE) is a favorite amongst institutional investors who own 66% - Yahoo Finance
24,749 Shares in uniQure (NASDAQ:QURE) Acquired by Palumbo Wealth Management LLC - MarketBeat
uniQure (NASDAQ:QURE) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
1.23%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):